ImmuniWeb and Cortex Xpanse are prominent players in cybersecurity platforms. Cortex Xpanse holds the upper hand with its comprehensive feature set, making it appealing to enterprises focused on detailed cybersecurity controls.
Features: ImmuniWeb offers AI-driven security testing, comprehensive threat intelligence, and clear compliance reporting. Cortex Xpanse provides expansive asset discovery, automated risk assessment, and extensive threat visibility, with a detailed mapping of threats providing a significant edge.
Room for Improvement: ImmuniWeb can improve in areas like expanding its global language support, enhancing customization options for different compliance needs, and refining its integration with various third-party tools. Cortex Xpanse could work on simplifying its deployment process, optimizing resource requirements, and enhancing its interface for non-technical users.
Ease of Deployment and Customer Service: ImmuniWeb is noted for its intuitive setup process and robust support services, making its deployment smoother. Cortex Xpanse, while offering a more comprehensive deployment model, may need a more involved integration process but compensates with responsive customer service, appealing to enterprises seeking depth.
Pricing and ROI: ImmuniWeb is recognized for its cost-effective pricing model, delivering good ROI through competitive setup costs. Cortex Xpanse, while potentially involving higher initial costs, provides significant value with its extensive feature set, often perceived as justifying the investment in terms of long-term value.
Xpanse provides a complete, accurate and continuously updated inventory of all global internet-facing assets. This allows you to discover, evaluate, and mitigate cyber attack surface risks. You can also evaluate supplier risk and assess the security of acquired companies.
Manual asset inventory maintenance is slow and prone to error. An outside-in view of your attack surface catches assets and exposures you never knew existed to help with attack surface reduction.
Get ahead of your ransomware risk assessment by discovering and remediating RDP exposures, the leading attack vector in ransomware attacks. Find exposed assets before attackers do.
Integration with Cortex XSOAR, Prisma Cloud, and our broader portfolio allows our ASM findings to enhance security workflows, and secure unknown, unmanaged risks on your cloud attack surface.
ImmuniWeb is a global application security company operating in over 50 countries, headquartered in Geneva, Switzerland. Most of ImmuniWeb's customers come from regulated industries, such as banking, healthcare, and e-commerce.
ImmuniWeb® AI Platform leverages award-winning AI and Machine Learning technology for acceleration and intelligent automation of Attack Surface Management and Dark Web Monitoring. The data is later leveraged for threat-aware and risk-based Application Penetration Testing for web, mobile, and API security testing. ImmuniWeb is the only company that offers a contractual zero false-positives SLA with a money-back guarantee. ImmuniWeb’s AI technology is a recipient of numerous awards and recognitions, including Gartner Cool Vendor, IDC Innovator, and the winner of “SC Award Europe” in the “Best Usage of Machine Learning and AI” category.
ImmuniWeb® Community Edition runs over 100,000 daily tests, being one of the largest application security communities. ImmuniWeb SA is an ISO 27001 certified and CREST-accredited company.
We monitor all Attack Surface Management (ASM) reviews to prevent fraudulent reviews and keep review quality high. We do not post reviews by company employees or direct competitors. We validate each review for authenticity via cross-reference with LinkedIn, and personal follow-up with the reviewer when necessary.